Impact of antibiotic use and prescribing policy in a Tunisian intensive care unit

被引:8
作者
Brahmi, N. [1 ]
Blel, Y. [1 ]
Kouraichi, N. [1 ]
Ben Hamouda, R. [1 ]
Thabet, H. [1 ]
Amamou, M. [1 ]
机构
[1] CAMU, Serv Reanimat Med Polyvalente, Tunis 1008, Tunisia
来源
MEDECINE ET MALADIES INFECTIEUSES | 2006年 / 36卷 / 09期
关键词
rationalized antibiotic use; antimicrobial resistance;
D O I
10.1016/j.medmal.2006.07.012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective. - The aim of this study was to assess the efficacy of local antibiotic policy in a Tunisian ICU. The predefined primary efficacy objectives were the decrease of antibiotic consumption, reduction of inappropriate antibiotic (ATB) use and antimicrobial resistance. Design. - This prospective intervention study lasted from January 2002 to December 2004. In the first study period or the baseline phase (from January to December 2002) we focused on physician education for ATB prescription practice. The second period concerned intervention (control of all ATB use). Results. - The number of infection episodes significantly decreased from 2002 to 2004; 198 infection episodes in 2002 (1.63 +/- 1.15 episodes/patient) versus 124 in 2003 (1.22 +/- 0.93) (P < 0.0008) versus 121 in 2004 (1.23 +/- 0.8) (P I < 0.0008). The number of ATB/prescription also significantly decreased from 1.85 +/- 1.3 in 2002 to 1.5 +/- 0.9 in 2003 (P = 0.02) and 1.5 +/- 1.4 in 2004 (PI = 0.05). Appropriateness of antibiotherapy improved during the intervention period: 65% in 2002 versus 86% in 2003 (P = 0.0003) and 81% in 2004 (PI = 0.02). The length of antibiotherapy in survivors was considerably reduced: 14.1 +/- 2.9 days in 2002 versus 11.9 +/- 1.2 days in 2003 (P < 10(-5)) and 10.9 +/- 2.5 days in 2004 (P < 10-5) with a significant reduction of antibiotherapy cost and length of stay (20.4 +/- 9 days in 2002 versus 18.3 +/- 6 days in 2003 and 16.9 +/- 8 days in 2004; P = 0.05; P1 = 0.02). There was a significant decrease of carbapenem resistant Enterobacteriaceae esp, Pseudomonas aeruginosa and Acinetobacter baumannii. (c) 2006 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:460 / 465
页数:6
相关论文
共 39 条
[1]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[2]  
Ariza J., 2004, Clinical Pulmonary Medicine, V11, P71, DOI 10.1097/01.cpm.0000117765.69788.33
[3]   Impact of restricting fluoroquinolone prescription on bacterial, resistance in an intensive care unit [J].
Aubert, G ;
Carricajo, A ;
Vautrin, AC ;
Guyomarc'h, S ;
Fonsale, N ;
Page, D ;
Brunel, P ;
Rusch, P ;
Zéni, F .
JOURNAL OF HOSPITAL INFECTION, 2005, 59 (02) :83-89
[4]  
BALLOW CH, 1988, DIAGN MICROBIAL INFE, V22, P651
[5]   A hospitalwide intervention program to optimize the quality of antibiotic use:: Impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance [J].
Bantar, C ;
Sartori, B ;
Vesco, E ;
Heft, C ;
Saúl, M ;
Salamone, F ;
Oliva, ME .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) :180-186
[6]   Indications for antibiotic use in ICU patients: a one-year prospective surveillance [J].
Bergmans, DCJJ ;
Bonten, MJM ;
Gaillard, CA ;
vanTiel, FH ;
vanderGeest, S ;
deLeeuw, PW ;
Stobberingh, EE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (04) :527-535
[7]   Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species:: Risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence [J].
Bisson, G ;
Fishman, NO ;
Patel, JB ;
Edelstein, PH ;
Lautenbach, E .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (05) :254-260
[8]   Economic impact of a prescribing protocol in an intensive care unit. [J].
Blanc, P ;
Gainnier, M ;
Granier, I ;
Guigues, V ;
Boussuges, A ;
Geissler, A ;
DurandGasselin, J .
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1997, 16 (07) :873-877
[9]   Economic impact of a rational use of antibiotics in intensive care [J].
Blanc, P ;
Von Elm, BE ;
Geissler, A ;
Granier, I ;
Boussuges, A ;
Gasselin, JD .
INTENSIVE CARE MEDICINE, 1999, 25 (12) :1407-1412
[10]  
Bonten Marc J M, 2004, Curr Opin Crit Care, V10, P364, DOI 10.1097/01.ccx.0000139362.68445.11